Condition: Cardiac Hypertrophy


rs1320448 in COL17A1 gene and Cardiac Hypertrophy PMID 21348951 2011 Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.

rs12757165 in ESRRG gene and Cardiac Hypertrophy PMID 21348951 2011 Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.

rs152528 in FGF1;SPRY4-AS1 gene and Cardiac Hypertrophy PMID 21348951 2011 Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.

rs12907914 in LINC02694;LOC105370781 gene and Cardiac Hypertrophy PMID 21348951 2011 Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.

rs3729931 in RAF1 gene and Cardiac Hypertrophy PMID 21348951 2011 Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.

PMID 17603482 2007 Germline gain-of-function mutations in RAF1 cause Noonan syndrome.

PMID 17603483 2007 Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.